News & Views03 Feb 2025Nature Medicine P: 1-2 Inhibition of ERα signaling induces lineage plasticity in vivo Mutations inESR1, which encodes estrogen receptor-α (ERα), drive resistance to approved endocrine therapies in breast cancer. We studied the molecular response to the investigational ER...
The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer. January 24, 2025 5 min read Save Q&A: Oncofertility innovator awarded National Medal of Science Few researchers can claim to be a pioneer in their field quite like Teresa K. Woodruff,...
In this episode of Meeting Mic, we bring you the highlights and insights from the San Antonio Breast Cancer Symposium 2024, as well as Healio’s top headlines from the meeting. December 17, 2024 5 min watch Save VIDEO: Study shows antibody-drug conjugate efficacy against HER2-low, HER2...
NewsTheralink Begins Testing New Biomarker Assay for Breast Cancer Tumors NewsUS Study Enrolling Women to Help Determine Best Screening Practices NewsNonprofit Highlights Importance of Global Teamwork for World Cancer Day NewsEnhertu Approved in EU for Inoperable, Advanced Breast Cancer ...
Breast Cancer Date Rank LiveRank Popular Oncology & Cancer Sardines, mackerel and other oily fish: The benefits of marine lipids in the fight against cancer The world's oceans represent a vast and largely untapped source of biodiversity, offering a high probability for the discovery of unique...
Follow the latest Breast Cancer news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to Breast Cancer notifications.
CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer....
Latest News FDA Approves T-DXd in HR+, HER2-Low/Ultralow Breast Cancer By Jordyn Sava January 28th 2025 The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast cancer, based on phase 3 DESTINY-Breast06 trial results. FDA...
CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer....
New report on women cancer rates The American Cancer Society finds cancer rates are increasing in women, surpassing men in some cases. Dr. Celine Gounder, CBS News medical contributor, joins "CBS Mornings" to discuss these troubling trends and their implications. Jan 17 02:17 Rising ...